Work

Ultralow Dose Rituximab Combined With IVIG Is Safe and Effective in Pemphigus Vulgaris: Single‐Center Review of 24 Patients

Year: 2025

Type: article

Abstract: We present a combined ultralow dose rituximab and intravenous immunoglobulin protocol for the treatment of moderate to severe pemphigus vulgaris which has been proven to be safe and effective in a series of 24 rituximab naïve patients.

Source: Australasian Journal of Dermatology

DOI: 10.1111/ajd.70003

Authors: Andrew Awad, Jessica McClatchy, Ann Ramirez, Tami Yap, Laura Scardamaglia

Institutions: The Royal Melbourne Hospital, Flinders University, The University of Melbourne, Royal Children's Hospital, Western Health, Western Hospital

Language: English

Topic: Autoimmune Bullous Skin Diseases

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416729160

FWCI: 0.598

Cites: 11

Cited by: 1

Related to: